Hirohisa Takano Selected Research

Organic Chemicals (Chemicals, Organic)

7/2017	Environmental pollution and allergies.
12/2016	Differences in allergic inflammatory responses in murine lungs: comparison of PM2.5 and coarse PM collected during the hazy events in a Chinese city.
4/2016	Differences in allergic inflammatory responses between urban PM2.5 and fine particle derived from desert-dust in murine lungs.
10/2014	Aggravation of ovalbumin-induced murine asthma by co-exposure to desert-dust and organic chemicals: an animal model study.
1/2013	Organic chemicals in diesel exhaust particles enhance picryl chloride-induced atopic dermatitis in NC/Nga mice.
3/2007	Components of diesel exhaust particles diversely enhance a variety of respiratory diseases related to infection or allergy: extracted organic chemicals and the residual particles after extraction differently affect respiratory diseases.
1/2007	Effects of components derived from diesel exhaust particles on lung physiology related to antigen.
12/2006	Effects of organic chemicals derived from ambient particulate matter on lung inflammation related to lipopolysaccharide.
11/2004	Components of diesel exhaust particles differentially affect lung expression of cyclooxygenase-2 related to bacterial endotoxin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirohisa Takano Research Topics

Disease

69	Inflammation (Inflammations) 12/2021 - 01/2002
39	Pneumonia (Pneumonitis) 12/2021 - 05/2002
38	Asthma (Bronchial Asthma) 01/2022 - 01/2002
17	Eosinophilia 01/2017 - 01/2008
13	Acute Lung Injury 04/2010 - 12/2002
12	Lung Injury 11/2013 - 04/2002
10	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 04/2002
10	Atopic Dermatitis (Atopic Eczema) 12/2021 - 08/2006
10	Hypersensitivity (Allergy) 10/2021 - 11/2005
7	Body Weight (Weight, Body) 01/2019 - 04/2004
6	Pancreatitis 04/2010 - 03/2005
6	Shock 04/2010 - 03/2005
6	Disseminated Intravascular Coagulation 04/2010 - 03/2005
5	Infections 01/2021 - 10/2004
5	Obesity 01/2019 - 10/2003
5	Respiratory Hypersensitivity 01/2019 - 12/2002
5	Lung Diseases (Lung Disease) 02/2014 - 04/2003
4	Allergic Rhinitis 11/2018 - 09/2007
4	Edema (Dropsy) 02/2018 - 05/2002
4	Hemorrhage 01/2013 - 05/2002
4	Arthritis (Polyarthritis) 01/2007 - 08/2003
3	Hyperplasia 08/2019 - 08/2007
3	Peritonitis 02/2013 - 09/2003
3	Pulmonary Emphysema 11/2010 - 03/2010
3	Pulmonary Edema 09/2006 - 12/2002
2	COVID-19 01/2021 - 12/2020
2	Disease Progression 01/2020 - 03/2010
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2017 - 07/2005
2	Fibrosis (Cirrhosis) 01/2015 - 03/2011
2	Skin Diseases (Skin Disease) 02/2014 - 03/2009
2	Colitis 05/2013 - 08/2004
2	Emphysema 11/2010 - 03/2010

Drug/Important Bio-Agent (IBA)

42	CytokinesIBA 01/2021 - 01/2002
31	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 02/2013 - 04/2002
30	Vehicle Emissions (Emissions, Vehicle)IBA 08/2021 - 04/2002
25	AllergensIBA 01/2022 - 01/2002
25	LipopolysaccharidesIBA 01/2017 - 12/2002
20	Particulate MatterIBA 01/2022 - 09/2006
19	SandIBA 07/2017 - 11/2005
16	ChemokinesIBA 01/2019 - 05/2002
14	OvalbuminIBA 01/2016 - 07/2002
14	EndotoxinsIBA 02/2011 - 05/2002
13	AntigensIBA 01/2014 - 12/2002
12	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2003
10	Immunoglobulin G (IgG)IBA 01/2019 - 01/2002
9	Diethylhexyl Phthalate (DEHP)IBA 10/2021 - 08/2006
9	Organic Chemicals (Chemicals, Organic)IBA 07/2017 - 11/2004
8	Immunoglobulins (Immunoglobulin)IBA 02/2014 - 07/2002
8	Proteins (Proteins, Gene)FDA Link 11/2010 - 04/2002
7	InterleukinsIBA 01/2021 - 06/2004
7	Interleukin-5 (Interleukin 5)IBA 11/2020 - 01/2002
7	phthalic acid (phthalate)IBA 07/2017 - 08/2006
7	Chemotactic FactorsIBA 02/2013 - 04/2004
7	urinastatin (MR 20)IBA 04/2010 - 03/2005
6	Immunoglobulin E (IgE)IBA 01/2019 - 01/2002
6	MetallothioneinIBA 05/2013 - 01/2005
6	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2010 - 03/2005
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2002
4	CarbonIBA 09/2017 - 09/2006
4	GlucansIBA 04/2016 - 07/2005
4	Interleukin-13IBA 01/2015 - 08/2005
4	SootIBA 04/2011 - 09/2006
4	Pharmaceutical PreparationsIBA 04/2010 - 03/2005
4	Rosmarinic AcidIBA 07/2006 - 04/2003
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
3	Benzo(a)pyreneIBA 12/2021 - 11/2016
3	bisphenol AIBA 01/2019 - 01/2016
3	PlasticizersIBA 07/2017 - 05/2009
3	Environmental Pollutants (Pollutants, Environmental)IBA 07/2017 - 05/2002
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014 - 04/2002
3	Pancreatic Elastase (Elastase)IBA 04/2011 - 03/2010
3	Carbon Nanotubes (Carbon Nanotube)IBA 04/2010 - 12/2008
3	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010 - 01/2004
3	AntioxidantsIBA 10/2009 - 12/2002
3	Vitamin E FDA LinkGeneric 10/2004 - 12/2002
2	titanium dioxide (Titania)FDA Link 12/2021 - 03/2009
2	Biological ProductsIBA 12/2021 - 11/2010
2	CholesterolIBA 01/2021 - 04/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2003
2	Air Pollutants (Pollutants, Air)IBA 01/2021 - 07/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2020 - 01/2020
2	Silicon Dioxide (Silica)FDA LinkGeneric 08/2019 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2014
2	Drinking WaterIBA 01/2019 - 08/2004
2	EstersIBA 07/2017 - 05/2009
2	quinone (benzoquinone)IBA 06/2017 - 01/2005
2	ElementsIBA 12/2016 - 04/2016
2	LigandsIBA 04/2016 - 03/2011
2	LipidsIBA 03/2014 - 12/2012
2	diisononyl phthalateIBA 02/2014 - 04/2010
2	OzoneIBA 12/2012 - 12/2008
2	PeroxiredoxinsIBA 12/2012 - 10/2009
2	Therapeutic UsesIBA 06/2012 - 05/2011
2	InflammasomesIBA 01/2012 - 10/2010
2	Methacholine Chloride (Methacholine)FDA Link 11/2010 - 03/2010
2	Cholinergic Agents (Cholinergics)IBA 11/2010 - 03/2010
2	Alkaline PhosphataseIBA 11/2010 - 03/2010
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2010 - 03/2010

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2015 - 12/2008